ENTX — Entera Bio Cashflow Statement
0.000.00%
Last trade - 00:00- $70.25m
- $59.23m
- 32
- 13
- 77
- 36
Annual cashflow statement for Entera Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 10-K | 10-K | 10-K | 10-K |
| Standards: | IFRS | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.8 | -11.2 | -12.2 | -13.1 | -8.89 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.919 | 0.947 | 1.88 | 2.17 | 1.69 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.719 | -0.351 | 1.41 | -1.83 | -0.195 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -8.92 | -10.6 | -9.06 | -12.5 | -7.31 |
| Capital Expenditures | -0.04 | -0.053 | -0.017 | -0.047 | -0.017 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 3.99 | — | — | -0.055 | 0 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 3.95 | -0.053 | -0.017 | -0.102 | -0.017 |
| Financing Cash Flow Items | — | — | — | — | -0.58 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 12.7 | 4.05 | 25.4 | 0.013 | 6.04 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.68 | -6.56 | 16.3 | -12.6 | -1.29 |